Singapore, June 07, 2010: Jiangbo Pharmaceuticals, a pharmaceutical company with its principal operations in China, said that the company has received approval to list its common stock on the NASDAQ Global Market.

Jiangbo anticipates that its common stock will begin trading on the NASDAQ Global Market on Tuesday, June 8, 2010, under the symbol 'JGBO'.

Commenting on the development, Mr Wubo Cao, Chief Executive Officer. “We are extremely pleased to meet the listing standards for NASDAQ Global Market, one of the world's preeminent stock exchanges, and would like to thank all of our supporters, including our investors and employees. We view this upgrade as a significant milestone in Jiangbo's development as a US publicly-traded company.”

The company anticipates that the move to the NASDAQ Global Market will help increase its visibility in the investment community, improve trading liquidity and broaden shareholder base.